This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
Adalimumab
40 mg/.4mL, Injection, solution
INN: ADALIMUMAB
Data updated: 2026-05-02
Available in:
🇨🇿🇩🇪🇬🇧🇫🇷🇯🇵🇸🇰
Form
INJECTION, SOLUTION
Dosage
40 mg/.4mL
Route
SUBCUTANEOUS
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Cordavis Limited
ATC Code
L04AB04
Source
OPENFDA_NDC
Adalimumab is prescribed to treat autoimmune disorders such as rheumatoid arthritis, ulcerative colitis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis.
It works by inhibiting a specific cell signal protein that causes inflammation.
⚠️ Warnings
• It may cause serious infection, which leads to death, contact your healthcare provider immediately if you have any signs of infection such as fever, cough, or flu-like symptoms.
• Perform lab test for tuberculosis before treatment. Monitor every patient for active tuberculosis while taking this medication.
• Tuberculosis treatment should be given prior to this medication.
• In some patients it may develop cancer like lymphoma.
• Caution should be exercised in patients with cancer, multiple sclerosis, heart disease, during pregnancy and breastfeeding.